MCT1 was also found to be an independent prognostic factor for PFS of Hodgkin lymphoma patients when included in a high metabolic heterogeneity group-high expression levels of TOMM2 and MCT1 in cancer cells and high MCT4 expression in macrophages [53]. Here, SLC16A1 is linked to cancer.